Showing results (81-90 of 125) with videos related to

Sort By:
Pageof 13
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 28, 2013
Antipsychotic response in first-episode schizophrenia: efficacy of high doses and switchingOfer Agid, Laura Schulze, Tamara Arenovich, et al.
Early Intervention in Psychiatry|May 31, 2012
Specialized home treatment versus hospital-based outpatient treatment for first-episode psychosis: a randomized clinical trialCarolyn S Dewa, Robert B Zipursky, Nancy Chau, et al.
Journal of Clinical Psychopharmacology|December 27, 2011
Tetrabenazine augmentation in treatment-resistant schizophrenia: a 12-week, double-blind, placebo-controlled trialGary Remington, Shitij Kapur, George Foussias, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 22, 2011
Time course of improvement with antipsychotic medication in treatment-resistant schizophreniaTakefumi Suzuki, Gary Remington, Tamara Arenovich, et al.
The American Journal of Psychiatry|April 4, 2007
Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophreniaRomina Mizrahi, Pablo Rusjan, Ofer Agid, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 2, 2006
Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophreniaOfer Agid, David Mamo, Nathalie Ginovart, et al.
The American Journal of Psychiatry|August 2, 2005
Six-month, blinded, multicenter continuation study of ziprasidone versus olanzapine in schizophreniaGeorge M Simpson, Peter Weiden, Theresa Pigott, et al.
CNS Spectrums|December 17, 2013
Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophreniaAntony D Loebel, Cynthia O Siu, Josephine B Cucchiaro, et al.
The Journal of Clinical Psychiatry|October 6, 2007
Ziprasidone in treatment-resistant schizophrenia: a 52-week, open-label continuation studyAntony D Loebel, Sumant Khanna, Sunita Rajadhyaksha, et al.
The American Journal of Psychiatry|October 7, 2004
Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorderGeorge M Simpson, Ira D Glick, Peter J Weiden, et al.
Pageof 13